COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination

Transpl Infect Dis. 2021 Aug;23(4):e13649. doi: 10.1111/tid.13649. Epub 2021 Jun 13.

Authors

Aris Tsalouchos¹, Gian Maria Rossolini^{2

3}, Laura Maggi², Alessio Mazzoni², Francesco Annunziato^{2

4}, Pietro Claudio Dattolo¹

Affiliations

¹ Department of Medicine, Division of Nephrology, Santa Maria Annunziata Hospital, Florence, Italy.
² Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
³ Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.
⁴ Flow Cytometry Diagnostic Center and Immunoterapy (CDCI), Careggi University Hospital, Florence, Italy.

No abstract available

Keywords: COVID-19; SARS-CoV-2 vaccination; kidney transplant.

Publication types

Letter
Comment

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
Kidney Transplantation* / adverse effects
RNA, Messenger
SARS-CoV-2
Transplant Recipients
Vaccination

Substances

COVID-19 Vaccines
RNA, Messenger